Post Reply
101-120 of 1176
A few Ks unrealised profit in about 1 and 1/2 month. Tempted to take profit but decided to go for the long haul. Afterall, buying with collecting dividend in mind and also to add if price turn down. Now may not be able to add at my ideal price range but existing holding should achieve higher yield on cost if the company pay out higher dividend, which is likely as they have committed to the new 50% payout ratio. Plus, there is a small chance for growth with businesses in China stabilising.
HVRRVH ( Date: 13-Jan-2025 18:24) Posted:
|
overall healthcare sector is experiencing mixed and mostly declined ..... facing huge competition from around.
board is into speculation .... driving the price up called good ..... 🤫 don' t laugh hor
board is into speculation .... driving the price up called good ..... 🤫 don' t laugh hor
gt more gov hosp in spore now....so private hosp will be quite competitive....Bedok hosp on the way, under construction now....
Tob231 ( Date: 26-Feb-2025 09:11) Posted:
|
when no buy back .... continue to go down. how can it be good stock ?
ownself push up
ownself push up
Good stock and everyday buy back will push it up
Raffles Medical jumps 6.7% on 100 million share buyback plan posts 4.3% rise in H2 profit to S$31.6 million
The board proposes a final dividend of S$0.025 per ordinary share
PRIVATE healthcare provider Raffles Medical Group : BSL +6.67% posted a 4.3 per cent rise in net profit to S$31.6 million for its second half ended Dec 31, 2024, from S$30.3 million in the previous corresponding period.
The group also intends to buy back up to 100 million shares, representing 5.3 per cent of its total ordinary issued shares, over the next two years, it said in a bourse filing on Monday (Feb 24).
Following the news, the counter jumped 6.7 per cent to peak at S$0.88 as at 10.24 am, and closed at this price on Monday.
In an earnings briefing after the results, executive chairman Dr Loo Choon Yong said the share buyback plan comes as the company&rsquo s cash flow is still strong.
He added that the group&rsquo s China operations continues to improve, and will eventually add to Raffles Medical&rsquo s cash flow.
&ldquo We want to grow the company, but if the cash is accumulating faster than we have opportunities to invest, then we will to distribute to shareholders,&rdquo he said.
The group has S$343.7 million in cash and cash equivalents, as at Dec 31. Dr Loo estimated that with Raffles Medical&rsquo s current share price, the amount spent would be less than S$100 million over the two years.
The group is also open to borrowing if necessary, and letting its cash flow catch up after, he added.
The board has proposed a final dividend of S$0.025 per ordinary share, up slightly from S$0.024 the year before. Once approved by shareholders, the dividend will be paid on May 23, after books closure on May 15.
The group also revised its dividend policy to pay out at least 50 per cent of its sustainable earnings annually. Dr Loo also did not rule out an occasional special dividend &ldquo when there&rsquo s a lot of cash&rdquo .
For the second half, earnings per share (EPS) was S$0.017, against an EPS of S$0.0163 previously.
Revenue for H2 climbed 14.8 per cent to S$385.9 million from S$336.2 million in the year-ago period.
For the full year, net profit was down 31 per cent year on year at S$62.2 million from S$90.2 million, translating to an EPS of S$0.0335 against S$0.0485 previously.
Revenue for the full year was up 6.3 per cent at S$751.6 million from S$706.9 million.
Stronger revenue for financial year 2024 came as the group&rsquo s hospital services division performed well for the year, the company said.
The division registered revenue growth of 4.6 per cent on the year to S$345.7 million, and a 9.5 per cent increase in profit before tax to S$35.7 million.
Its healthcare services division logged revenue growth of 4.1 per cent from S$283.4 million to S$295.1 million. However, its profit before tax declined 33 per cent to S$45.1 million due to fewer government grants, and the cessation of Covid-19 services in 2024 compared with 2023.
Views on China, SEZ
Dr Loo expects the group&rsquo s China hospitals to break even in one to two years, noting that its Beijing hospital has been profitable for some time.
He is optimistic on China as Raffles Medical has gained traction there, with the majority of its patients being Chinese.
In addition, he views the Chinese government&rsquo s move to allow foreign players to wholly own hospitals in certain regions as a positive step towards liberalising the healthcare market.
Prior to the change, foreign players could only own up to 70 per cent of a hospital in China, usually through joint ventures.
Foreign players fully owning the hospital would allow them to avoid any &ldquo partnership issues&rdquo , said Dr Loo. And should foreign operators still aim to have local participation, the changed rule would make it easier to choose partners that meet their requirements, he said.
However, Dr Loo believes it will be some time before new foreign players capitalise on this policy.
Meanwhile, rising costs threaten to compromise Singapore&rsquo s appeal as a regional healthcare hub, but the company intends to mediate this by pursuing long-term growth opportunities in other markets, said Raffles Medical.
That said, Singapore is known for its standard of care, and patients with serious illnesses who can afford the premiums are likely to come to the city-state for better treatment, he noted.
As for the Johor-Singapore Special Economic Zone, Dr Loo said the group has some associate clinics in Malaysia, but is evaluating if it should set up some facilities there.
While most Singaporeans will stay home for subsidised medical care, &ldquo people may want to go (to Malaysia) for health screening or wellness&rdquo , he said.
90 cents base established, Not sure management started SBB already or not today but regardless, 50% dividend payout ratio is attractive especially if holding cost is lower than current price. Besides, still got small chance for growth. Should accumulate on price weakness.
HVRRVH ( Date: 24-Feb-2025 10:31) Posted:
|
Share buyback auto push
$1.20 firsr
will it cheong until $1.50??
ST:
Raffles Medical shares jump 6.7 percent on new dividend policy, share buyback plan
https://www.straitstimes.com/business/companies-markets/raffles-medical-posts-4-3-rise-in-second-half-profit-to-31-6-million
Raffles Medical shares jump 6.7 percent on new dividend policy, share buyback plan
https://www.straitstimes.com/business/companies-markets/raffles-medical-posts-4-3-rise-in-second-half-profit-to-31-6-million
According to Sakura research, Raffles stock price still has a lot of upside.
Raffles has amazing singapore commercial investment properties - in real estate.
a lot of cash on its balance sheet, with net cash position.
Based on Net Tangible Book Value peer (IHH) comparison valuation, and under-appraised prime Singapore properties ripe for mark-to-market fair value gains,
RMG should be trading at a market cap of over S$5 billion, instead of its current market cap of about S$1.66 billion only.
DYODD
Raffles has amazing singapore commercial investment properties - in real estate.
a lot of cash on its balance sheet, with net cash position.
Based on Net Tangible Book Value peer (IHH) comparison valuation, and under-appraised prime Singapore properties ripe for mark-to-market fair value gains,
RMG should be trading at a market cap of over S$5 billion, instead of its current market cap of about S$1.66 billion only.
DYODD
Raffles Med Group intends to buy back up to 100 million ordinary shares over the next two years.
This means on average about 50 million shares a year,
Dr Loo only bought about 49,020,000 shares in 2024.
This means on average about 50 million shares a year,
Dr Loo only bought about 49,020,000 shares in 2024.
| Date Purchase | No. of shares purchase |
| 27 Feb 2024 | 3,500,000 |
| 28 Feb 2024 | 1,000,000 |
| 29 Feb 2024 | 1,400,000 |
| 1 Mar 2024 | 1,100,000 |
| 4 Mar 2024 | 1,000,000 |
| 5 Mar 2024 | 1,600,000 |
| 6 Mar 2024 | 1,300,000 |
| 7 Mar 2024 | 800,000 |
| 8 Mar 2024 | 600,000 |
| 11 Mar 2024 | 500,000 |
| 12 Mar 2024 | 500,000 |
| 13 Mar 2024 | 300,000 |
| 14 Mar 2024 | 200,000 |
| 15 Mar 2024 | 200,000 |
| 19 Mar 2024 | 100,000 |
| 20 Mar 2024 | 200,000 |
| 21 Mar 2024 | 200,000 |
| 25 Mar 2024 | 400,000 |
| 3 May 2024 | 500,000 |
| 6 May 2024 | 1,000,000 |
| 7 May 2024 | 1,000,000 |
| 9 May 2024 | 1,000,000 |
| 10 May 2024 | 300,000 |
| 13 May 2024 | 100,000 |
| 14 May 2024 | 500,000 |
| 15 May 2024 | 700,000 |
| 16 May 2024 | 600,000 |
| 17 May 2024 | 1,000,000 |
| 20 May 2024 | 500,000 |
| 23 May 2024 | 150,000 |
| 24 May 2024 | 300,000 |
| 27 May 2024 | 400,000 |
| 29 May 2024 | 700,000 |
| 31 May 2024 | 900,000 |
| 3 Jun 2024 | 400,000 |
| 5 Jun 2024 | 1,000,000 |
| 6 Jun 2024 | 800,000 |
| 10 Jun 2024 | 500,000 |
| 11 Jun 2024 | 1,000,000 |
| 12 Jun 2024 | 800,000 |
| 13 Jun 2024 | 200,000 |
| 14 Jun 2024 | 500,000 |
| 18 Jun 2024 | 500,000 |
| 19 Jun 2024 | 1,500,000 |
| 20 Jun 2024 | 800,000 |
| 21 Jun 2024 | 1,000,000 |
| 26 Jun 2024 | 1,500,000 |
| 27 Jun 2024 | 800,000 |
| 1 Aug 2024 | 1,400,000 |
| 2 Aug 2024 | 800,000 |
| 5 Aug 2024 | 800,000 |
| 6 Aug 2024 | 600,000 |
| 12 Aug 2024 | 800,000 |
| 24 Sept 2024 | 1,700,000 |
| 25 Sept 2024 | 450,000 |
| 26 Sept 2024 | 470,000 |
| 29 Oct 2024 | 1,100,000 |
| 30 Oct 2024 | 1,000,000 |
| 11 Nov 2024 | 1,500,000 |
| 18 Nov 2024 | 150,000 |
| 22 Nov 2024 | 1,000,000 |
| 26 Nov 2024 | 700,000 |
| 27 Nov 2024 | 700,000 |
| Total | 49,020,000 |
alexvar ( Date: 24-Feb-2025 06:37) Posted:
|
So far it?s been right and with management?s commitment to buy back shares, the stock is now trying to establish a base price, let?s hope it is at least 90 cents since founder has bought around and higher than this price recently
HVRRVH ( Date: 13-Jan-2025 18:24) Posted:
|
Let' s see if it can cross the $0.9 line today.
looks like a rocket!
looks like a rocket!
Results show signs of improvement. Dividend sustained and intended 100m SBB should arrest any irrational negative market movements. Looking to add for long term on price weakness.
Raffles Med Group intends to buy back up to 100 million ordinary shares over the next two years !
Healthy cash position of S$343.7 million.
Excluding fair value gain of investment properties, PATMI for 2H2024 grew 38 percent !
compared to adjusted PATMI of S$22.9 million in 2H2023
Revenue grew 6.3 percent to S$751.6 million!
Given its strong positive operating cash flow, the Group has revised its dividend policy to pay out at least 50 per cent of its sustainable earnings annually.
Great results. Vested!
Healthy cash position of S$343.7 million.
Excluding fair value gain of investment properties, PATMI for 2H2024 grew 38 percent !
compared to adjusted PATMI of S$22.9 million in 2H2023
Revenue grew 6.3 percent to S$751.6 million!
Given its strong positive operating cash flow, the Group has revised its dividend policy to pay out at least 50 per cent of its sustainable earnings annually.
Great results. Vested!
Let' s see if the new manager can' t stop the bleeding @ Raffles China hospitals.
https://www.tipranks.com/news/company-announcements/raffles-medical-group-strengthens-leadership-in-china-with-new-appointment
Raffles Medical Group has appointed Mr. Phua Tien Beng as the Deputy Managing Director of Raffles China Healthcare.
With over 20 years of experience in the healthcare sector in Singapore and China, Mr. Phua is expected to lead the development and operational management of the business portfolio in Greater China, enhancing the group&rsquo s presence and strategic positioning in the region.
https://www.tipranks.com/news/company-announcements/raffles-medical-group-strengthens-leadership-in-china-with-new-appointment
Raffles Medical Group has appointed Mr. Phua Tien Beng as the Deputy Managing Director of Raffles China Healthcare.
With over 20 years of experience in the healthcare sector in Singapore and China, Mr. Phua is expected to lead the development and operational management of the business portfolio in Greater China, enhancing the group&rsquo s presence and strategic positioning in the region.
MOH portal, S&rsquo pore clinics see surge in demand for influenza vaccination after Barbie Hsu&rsquo s death.
Raffles Medical Group observed a 20 per cent increase in flu vaccination demand across its network of more than 40 family medicine clinics in the week following Hsu&rsquo s death. https://www.straitstimes.com/singapore/moh-portal-spore-clinics-see-surge-in-people-getting-influenza-vaccine-after-barbie-hsus-death
Raffles Medical Group observed a 20 per cent increase in flu vaccination demand across its network of more than 40 family medicine clinics in the week following Hsu&rsquo s death. https://www.straitstimes.com/singapore/moh-portal-spore-clinics-see-surge-in-people-getting-influenza-vaccine-after-barbie-hsus-death
RMG has risen from $0.062 to the current $0.825 since the start of trading.
-> $0.6 possible?
-> $0.6 possible?